Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells

Fang Li, Amy M. Munchhof, Hilary A. White, Laura E. Mead, Theresa R. Krier, Amy Fenoglio, Shi Chen, Xiaohua Wu, Shanbao Cai, Feng-Chun Yang, David A. Ingram

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions as a negative regulator of Ras activity. NF1 patients develop renal artery stenosis and arterial occlusions resulting in cerebral and visceral infarcts. Further, NF1 patients develop vascular neurofibromas where tumor vessels are invested in a dense pericyte sheath. Although it is well established that aberrations in Ras signaling lead to human malignancies, emerging data generated in genetically engineered mouse models now implicate perturbations in the Ras signaling axis in vascular smooth muscular cells (VSMCs) as central to the initiation and progression of neointimal hyperplasia and arterial stenosis. Despite these observations, the function of neurofibromin in regulating VSMC function and how Ras signals are terminated in VSMCs is virtually unknown. Utilizing VSMCs harvested from Nf1+/- mice and primary human neurofibromin-deficient VSMCs, we identify a discrete Ras effector pathway, which is tightly regulated by neurofibromin to limit VSMC proliferation and migration. Thus, these studies identify neurofibromin as a novel regulator of Ras activity in VSMCs and provide a framework for understanding cardiovascular disease in NF1 patients and a mechanism by which Ras signals are attenuated for maintaining VSMC homeostasis in blood vessel walls.

Original languageEnglish (US)
Pages (from-to)1921-1930
Number of pages10
JournalHuman Molecular Genetics
Volume15
Issue number11
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Neurofibromin 1
Vascular Smooth Muscle
Smooth Muscle Myocytes
Blood Vessels
Neurofibroma
Pericytes
Inborn Genetic Diseases
Renal Artery Obstruction
Neurofibromatosis 1
Tumor Suppressor Genes
Cell Movement
Hyperplasia
Neoplasms
Pathologic Constriction
Homeostasis
Cardiovascular Diseases

ASJC Scopus subject areas

  • Genetics

Cite this

Li, F., Munchhof, A. M., White, H. A., Mead, L. E., Krier, T. R., Fenoglio, A., ... Ingram, D. A. (2006). Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. Human Molecular Genetics, 15(11), 1921-1930. https://doi.org/10.1093/hmg/ddl114

Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. / Li, Fang; Munchhof, Amy M.; White, Hilary A.; Mead, Laura E.; Krier, Theresa R.; Fenoglio, Amy; Chen, Shi; Wu, Xiaohua; Cai, Shanbao; Yang, Feng-Chun; Ingram, David A.

In: Human Molecular Genetics, Vol. 15, No. 11, 06.2006, p. 1921-1930.

Research output: Contribution to journalArticle

Li, F, Munchhof, AM, White, HA, Mead, LE, Krier, TR, Fenoglio, A, Chen, S, Wu, X, Cai, S, Yang, F-C & Ingram, DA 2006, 'Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells', Human Molecular Genetics, vol. 15, no. 11, pp. 1921-1930. https://doi.org/10.1093/hmg/ddl114
Li, Fang ; Munchhof, Amy M. ; White, Hilary A. ; Mead, Laura E. ; Krier, Theresa R. ; Fenoglio, Amy ; Chen, Shi ; Wu, Xiaohua ; Cai, Shanbao ; Yang, Feng-Chun ; Ingram, David A. / Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. In: Human Molecular Genetics. 2006 ; Vol. 15, No. 11. pp. 1921-1930.
@article{aca5e3f0aa1e40cdb5355859acc33e13,
title = "Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells",
abstract = "Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions as a negative regulator of Ras activity. NF1 patients develop renal artery stenosis and arterial occlusions resulting in cerebral and visceral infarcts. Further, NF1 patients develop vascular neurofibromas where tumor vessels are invested in a dense pericyte sheath. Although it is well established that aberrations in Ras signaling lead to human malignancies, emerging data generated in genetically engineered mouse models now implicate perturbations in the Ras signaling axis in vascular smooth muscular cells (VSMCs) as central to the initiation and progression of neointimal hyperplasia and arterial stenosis. Despite these observations, the function of neurofibromin in regulating VSMC function and how Ras signals are terminated in VSMCs is virtually unknown. Utilizing VSMCs harvested from Nf1+/- mice and primary human neurofibromin-deficient VSMCs, we identify a discrete Ras effector pathway, which is tightly regulated by neurofibromin to limit VSMC proliferation and migration. Thus, these studies identify neurofibromin as a novel regulator of Ras activity in VSMCs and provide a framework for understanding cardiovascular disease in NF1 patients and a mechanism by which Ras signals are attenuated for maintaining VSMC homeostasis in blood vessel walls.",
author = "Fang Li and Munchhof, {Amy M.} and White, {Hilary A.} and Mead, {Laura E.} and Krier, {Theresa R.} and Amy Fenoglio and Shi Chen and Xiaohua Wu and Shanbao Cai and Feng-Chun Yang and Ingram, {David A.}",
year = "2006",
month = "6",
doi = "10.1093/hmg/ddl114",
language = "English (US)",
volume = "15",
pages = "1921--1930",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells

AU - Li, Fang

AU - Munchhof, Amy M.

AU - White, Hilary A.

AU - Mead, Laura E.

AU - Krier, Theresa R.

AU - Fenoglio, Amy

AU - Chen, Shi

AU - Wu, Xiaohua

AU - Cai, Shanbao

AU - Yang, Feng-Chun

AU - Ingram, David A.

PY - 2006/6

Y1 - 2006/6

N2 - Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions as a negative regulator of Ras activity. NF1 patients develop renal artery stenosis and arterial occlusions resulting in cerebral and visceral infarcts. Further, NF1 patients develop vascular neurofibromas where tumor vessels are invested in a dense pericyte sheath. Although it is well established that aberrations in Ras signaling lead to human malignancies, emerging data generated in genetically engineered mouse models now implicate perturbations in the Ras signaling axis in vascular smooth muscular cells (VSMCs) as central to the initiation and progression of neointimal hyperplasia and arterial stenosis. Despite these observations, the function of neurofibromin in regulating VSMC function and how Ras signals are terminated in VSMCs is virtually unknown. Utilizing VSMCs harvested from Nf1+/- mice and primary human neurofibromin-deficient VSMCs, we identify a discrete Ras effector pathway, which is tightly regulated by neurofibromin to limit VSMC proliferation and migration. Thus, these studies identify neurofibromin as a novel regulator of Ras activity in VSMCs and provide a framework for understanding cardiovascular disease in NF1 patients and a mechanism by which Ras signals are attenuated for maintaining VSMC homeostasis in blood vessel walls.

AB - Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions as a negative regulator of Ras activity. NF1 patients develop renal artery stenosis and arterial occlusions resulting in cerebral and visceral infarcts. Further, NF1 patients develop vascular neurofibromas where tumor vessels are invested in a dense pericyte sheath. Although it is well established that aberrations in Ras signaling lead to human malignancies, emerging data generated in genetically engineered mouse models now implicate perturbations in the Ras signaling axis in vascular smooth muscular cells (VSMCs) as central to the initiation and progression of neointimal hyperplasia and arterial stenosis. Despite these observations, the function of neurofibromin in regulating VSMC function and how Ras signals are terminated in VSMCs is virtually unknown. Utilizing VSMCs harvested from Nf1+/- mice and primary human neurofibromin-deficient VSMCs, we identify a discrete Ras effector pathway, which is tightly regulated by neurofibromin to limit VSMC proliferation and migration. Thus, these studies identify neurofibromin as a novel regulator of Ras activity in VSMCs and provide a framework for understanding cardiovascular disease in NF1 patients and a mechanism by which Ras signals are attenuated for maintaining VSMC homeostasis in blood vessel walls.

UR - http://www.scopus.com/inward/record.url?scp=33744768354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744768354&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddl114

DO - 10.1093/hmg/ddl114

M3 - Article

C2 - 16644864

AN - SCOPUS:33744768354

VL - 15

SP - 1921

EP - 1930

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 11

ER -